TickerFactsScreenerDevelopers

Coherus Oncology, Inc. (CHRS) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$38.52M2013: -$35.99M2014: -$64.68M2015: -$219.07M2016: -$115.93M2017: -$232.14M2018: -$204.42M2019: $107.77M2020: $156.32M2021: -$263.86M2022: -$256.88M2023: -$203.20M2024: -$199.65M2025: -$181.13M-$181.13M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$181.13M+9.3%
2024-$199.65M+1.7%
2023-$203.20M+20.9%
2022-$256.88M+2.6%
2021-$263.86M-268.8%
2020$156.32M+45.1%
2019$107.77M+152.7%
2018-$204.42M+11.9%
2017-$232.14M-100.2%
2016-$115.93M+47.1%
2015-$219.07M-238.7%
2014-$64.68M-79.7%
2013-$35.99M+6.6%
2012-$38.52M—